Synthesis and cytotoxic activity of 17-carboxylic acid modified 23-hydroxy betulinic acid ester derivatives

Bioorganic & Medicinal Chemistry Letters
2007.0

Abstract

New 17-carboxylic acid modified 23-hydroxy betulinic acid ester derivatives were prepared and tested for cytotoxic activity on five cancer cell lines in vitro: all tested compounds showed stronger cytotoxic activity than 23-hydroxy betulinic acid and betulinic acid. In addition, compound 5a was tested for anti-tumor activity in vivo: it had much better anti-tumor activity than 23-OH betulinic acid and had similar anti-tumor activity with cyclophosphamide and 5-fluorouracil.

Knowledge Graph

Similar Paper

Synthesis and cytotoxic activity of 17-carboxylic acid modified 23-hydroxy betulinic acid ester derivatives
Bioorganic & Medicinal Chemistry Letters 2007.0
Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives
European Journal of Medicinal Chemistry 2011.0
Synthesis and antitumor activity of novel 3-oxo-23-hydroxybetulinic acid derivatives
European Journal of Medicinal Chemistry 2014.0
Betulinic acid derived hydroxamates and betulin derived carbamates are interesting scaffolds for the synthesis of novel cytotoxic compounds
European Journal of Medicinal Chemistry 2015.0
Synthesis and structure–activity relationship study of novel cytotoxic carbamate and N-acylheterocyclic bearing derivatives of betulin and betulinic acid
Bioorganic & Medicinal Chemistry 2010.0
Synthesis of heterocycle-modified betulinic acid derivatives as antitumor agents
European Journal of Medicinal Chemistry 2015.0
Synthesis, in vitro and in vivo antitumor activity of pyrazole-fused 23-hydroxybetulinic acid derivatives
Bioorganic & Medicinal Chemistry Letters 2015.0
Synthesis and in vitro antitumor evaluation of betulin acid ester derivatives as novel apoptosis inducers
European Journal of Medicinal Chemistry 2015.0
Synthesis and Antitumor Activity of Cyclopropane Derivatives of Betulinic and Betulonic Acids
Russian Journal of Bioorganic Chemistry 2005.0
Synthesis, biological evaluation and mechanism studies of C-23 modified 23-hydroxybetulinic acid derivatives as anticancer agents
European Journal of Medicinal Chemistry 2019.0